NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Institute for Health and Care Excellence (NICE): NICE Process and Methods Guides [Internet].
This interim process statement has been produced to guide the development of good practice guidance. It provides an overview of the key process principles and describes all stages of the development of good practice guidance. These procedures are designed to ensure that a robust, quality-assured, resource is developed for the NHS in an open, transparent and timely way, with appropriate input from key groups.
This interim process statement of good practice guidance will be superseded when the final process guide is issued later in 2012, following engagement and discussions with key groups.
Preliminary version: HTML in process
- NLM CatalogRelated NLM Catalog Entries
- Review Key Therapeutic Topics – Medicines Management Options for Local Implementation: Interim Process Statement[ 2013]Review Key Therapeutic Topics – Medicines Management Options for Local Implementation: Interim Process StatementNational Institute for Health and Care Excellence. 2013 Jan 31
- Review Good Practice Guidance – Integratedated Process Statement[ 2013]Review Good Practice Guidance – Integratedated Process StatementNational Institute for Health and Care Excellence. 2013 May 7
- Review Evidence Summaries: New Medicines – Interim Process Statement[ 2012]Review Evidence Summaries: New Medicines – Interim Process StatementNational Institute for Health and Care Excellence. 2012 Jun 1
- Review Evidence Summaries: Unlicensed and Off-Label Medicines – Interim Process Statement[ 2012]Review Evidence Summaries: Unlicensed and Off-Label Medicines – Interim Process StatementNational Institute for Health and Care Excellence. 2012 Aug 7
- Review Medicines Optimisation: Key Therapeutic Topics – Integrated Process Statement[ 2013]Review Medicines Optimisation: Key Therapeutic Topics – Integrated Process StatementNational Institute for Health and Care Excellence. 2013 May 7
- Good Practice Guidance – Interim Process StatementGood Practice Guidance – Interim Process Statement
- "895542-94-6"[CompleteSynonym] (1)PubChem Compound
- TSA: Onchocerca flexuosa mRNA sequenceTSA: Onchocerca flexuosa mRNA sequencegi|328557411|gnl|gpid:65265|isotig2 OnflCeel|gb|JI460617.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...